China Pharma Holdings, Inc.
CPHI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106644
No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.
Holders of 5% or more of CPHI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of China Pharma Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of China Pharma Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on China Pharma Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 26, 2024 | Liu Tao (Chengdu) | 13GOld format | – | New | – | SEC |
| Jan 12, 2024 | Streeterville Capital LLC | 13G/AOld format | – | – | – | SEC |
| Mar 9, 2023 | Deng Ke | 13GOld format | – | New | – | SEC |
| Dec 5, 2022 | Streeterville Capital LLC | 13G/AOld format | – | – | – | SEC |
| Sep 27, 2022 | Streeterville Capital LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell China Pharma Holdings, Inc. shares.
No Form 144 notices for China Pharma Holdings, Inc. are on file.